欢迎来到天天文库
浏览记录
ID:5414515
大小:1.23 MB
页数:5页
时间:2017-12-10
《短脉冲模式扫描激光治疗糖尿病视网膜病变疗效观察》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、万方数据152中华眼底病杂志2014年3月第30卷第2期ChinJOculFundusDis,March2014,V01.30,No.2·糖尿病视网膜病变研究·短脉冲模式扫描激光治疗糖尿病视网膜病变疗效观察吴培培叶海昀钟晓菁田臻欧杰雄于珊珊林婉意金陈进【摘要】目的观察短脉冲模式扫描激光(PASCAL)系统全视网膜激光光凝(PRP)(PASCAL-PRP)治疗糖尿病视网膜病变(DR)的疗效。方法临床检查确诊的DR患者43例70只眼纳入研究。其中,男性19例32只眼,女性24例38只眼;年龄45477岁。视力≥o.1者62只眼,2、黄斑水肿者18只眼。严重非增生型DR(NPDR)28只眼,增生型DR(PDR)42只眼。所有患眼均行1次PASCAL-PRP治疗。伴黄斑水肿者应用PASCAL单点模式和黄斑模式(MACA+MACB)。观察治疗后1年患眼视力、视网膜新生血管、黄斑水肿改善情况。结果70只眼中,视力提高、稳定、下降者分别为10、53、7只眼;黄斑水肿改善、加重、稳定者分别为38、12、20只眼。PDR42只眼中,视网膜新生血管消退20只眼;视网膜新生血管病灶稳定11只眼;视网膜新生血管病灶活动11只眼。视网膜新生血管病灶活动者,随访期间给予1~2次补充激光光凝治疗。3、其中因玻璃体积血、出现增生牵拉行玻璃体切割手术治疗3只眼。结论PASCAL可以选择多种模式治疗DR安全有效。【关键词】糖尿病视网膜病变/治疗;激光凝固术中图分类号:R774.1R587.26Preliminaryclinicalobservationofshort-pulsepatternscanlaserphotocoagulationtreatmentindiabeticretinopathyWuPeipei,YeHaiyun,ZhongXiaojing,eta1.ZhongshanOphthalmicCenter,SunYat—SenUn4、iversity,Guangzhou510060,ChinaCorrespondingauthor:JinChenjin,Email:jinchj@mail.sysu.edu.Cn【Abstract]ObjectiveToinvestigatetheclinicaloutcomeandtherapeuticefficacyofshort—pulsepatternscanlaser(PASCAL)photocoagulationfordiabeticretinopathy(DR).MethodsForty—threeDRpatients(70ey5、es)including19males(32eyes)and24females(38eyes)underwentshort—pulsePASCALpan-retinalphotocoagulation(PRP).Therewere24patients<42eyes)withproliferativediabeticretinopathy(PDR)and19patients(28eyes)withseverenon-proliferativediabeticretinopathy(NPDR).Thebestcorrectedvisualacuit6、ywasbetterthanorequaltO0.1in62eyes。worsethan0.1in8eyes,Diabeticmacularedemawasfoundin18eyes.Short—pulsePASCALPRPwasappliedwithmulti—spotarrays.MacularedemawastreatedbyPASCALmacularmode(MACA+MACB)and/orsinglespot.Visualacuityandfundusexaminationswereanalyzedattheone-yearfollo7、w—upprocedure.ResultsOneyearaftershort—pulsePASCALtreatment,thefinalvisualacuitywasimprovedin10eyes,stablein53eyes,decreasedin7eyes;macularedemawasrelievedin38eyes,aggravatedin12eyes,andstablein20eyes.Of42eyeswithPDR,neovascularizationwereregressedin20eyes,uncontrolledin1eye8、swhichexperiencedadditionalphotocoagulation(1—2times)duringthefollow—up.Amo
2、黄斑水肿者18只眼。严重非增生型DR(NPDR)28只眼,增生型DR(PDR)42只眼。所有患眼均行1次PASCAL-PRP治疗。伴黄斑水肿者应用PASCAL单点模式和黄斑模式(MACA+MACB)。观察治疗后1年患眼视力、视网膜新生血管、黄斑水肿改善情况。结果70只眼中,视力提高、稳定、下降者分别为10、53、7只眼;黄斑水肿改善、加重、稳定者分别为38、12、20只眼。PDR42只眼中,视网膜新生血管消退20只眼;视网膜新生血管病灶稳定11只眼;视网膜新生血管病灶活动11只眼。视网膜新生血管病灶活动者,随访期间给予1~2次补充激光光凝治疗。
3、其中因玻璃体积血、出现增生牵拉行玻璃体切割手术治疗3只眼。结论PASCAL可以选择多种模式治疗DR安全有效。【关键词】糖尿病视网膜病变/治疗;激光凝固术中图分类号:R774.1R587.26Preliminaryclinicalobservationofshort-pulsepatternscanlaserphotocoagulationtreatmentindiabeticretinopathyWuPeipei,YeHaiyun,ZhongXiaojing,eta1.ZhongshanOphthalmicCenter,SunYat—SenUn
4、iversity,Guangzhou510060,ChinaCorrespondingauthor:JinChenjin,Email:jinchj@mail.sysu.edu.Cn【Abstract]ObjectiveToinvestigatetheclinicaloutcomeandtherapeuticefficacyofshort—pulsepatternscanlaser(PASCAL)photocoagulationfordiabeticretinopathy(DR).MethodsForty—threeDRpatients(70ey
5、es)including19males(32eyes)and24females(38eyes)underwentshort—pulsePASCALpan-retinalphotocoagulation(PRP).Therewere24patients<42eyes)withproliferativediabeticretinopathy(PDR)and19patients(28eyes)withseverenon-proliferativediabeticretinopathy(NPDR).Thebestcorrectedvisualacuit
6、ywasbetterthanorequaltO0.1in62eyes。worsethan0.1in8eyes,Diabeticmacularedemawasfoundin18eyes.Short—pulsePASCALPRPwasappliedwithmulti—spotarrays.MacularedemawastreatedbyPASCALmacularmode(MACA+MACB)and/orsinglespot.Visualacuityandfundusexaminationswereanalyzedattheone-yearfollo
7、w—upprocedure.ResultsOneyearaftershort—pulsePASCALtreatment,thefinalvisualacuitywasimprovedin10eyes,stablein53eyes,decreasedin7eyes;macularedemawasrelievedin38eyes,aggravatedin12eyes,andstablein20eyes.Of42eyeswithPDR,neovascularizationwereregressedin20eyes,uncontrolledin1eye
8、swhichexperiencedadditionalphotocoagulation(1—2times)duringthefollow—up.Amo
此文档下载收益归作者所有